| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/05/2004 | CN1493685A Glutamine transaminase high productive bacteria and its screening method and fermentation method producing glutamine transaminase using said bacterial strain |
| 05/05/2004 | CN1493684A New acid resistant and cholate resistant lactobacillus isolated strain having reducing and assimilating cholesterol ability |
| 05/05/2004 | CN1493683A Microorganism composite fungus agent for promoting agricultural waste quickly rotten and its making method |
| 05/05/2004 | CN1493597A Separation dendron shaped cell membrane protein gene |
| 05/05/2004 | CN1493549A High efficiency green biological compound parricle ferfilizer and its production method |
| 05/05/2004 | CN1148451C Biosynthesis method enabling preparation of cobalamins |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148449C Mutants of streptococcal toxin C and methods of use |
| 05/05/2004 | CN1148448C DNA for coding complete malaria antigene gp 190/MSP1, preparing process and use thereof |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148444C Protease variants and compositions |
| 05/05/2004 | CN1148442C Reduction of phosphorus containing components in edible oils comprising high amount of non-hydratable phosphorus by use of phospholipase from filamentous fungus having phospholipase A and/orB activity |
| 05/05/2004 | CN1148441C Novel engineering colibacillus G830 |
| 05/05/2004 | CN1148440C Feed product |
| 05/05/2004 | CN1148439C Bacterioflora for making raw strong-smelling preserved bean curd and bittern composition and method for making raw strong-smelling preserved bean curd |
| 05/05/2004 | CN1148382C Cathepsin O2 protease |
| 05/04/2004 | US6730823 Plant choline phosphate cytidylyltransferase |
| 05/04/2004 | US6730778 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/04/2004 | US6730634 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and method for identifying the same |
| 05/04/2004 | US6730508 Derived from pseudonocardia thermophila; a recombinant plasmid containing the gene; for synthesis of large amounts of the enzyme |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730504 Bacillus natto culture extract |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730479 Detection of nucleic acid hybrids |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/01/2004 | CA2447586A1 Improved hematology reagent and methods |
| 04/29/2004 | WO2004035813A2 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 04/29/2004 | WO2004035795A1 Vector for anti-hpv vaccine and transformed microorganism by the vector |
| 04/29/2004 | WO2004035794A1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
| 04/29/2004 | WO2004035792A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 04/29/2004 | WO2004035780A1 Gene expression vector using echinus-origin insulators |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035756A2 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN |
| 04/29/2004 | WO2004035070A1 Induction of gene expression using a high concentration sugar mixture |
| 04/29/2004 | WO2004034989A2 Probiotic bacteria |
| 04/29/2004 | WO2004020640A3 Zinc-regulated prokaryotic expression cassettes |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004008850A3 Process for sonicating plant seeds |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003078604A3 Tobacco rattle virus vectors and related compositions and methods |
| 04/29/2004 | WO2003075840A3 Human antibodies specific to kdr and uses thereof |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003060127A3 Genes and proteins involved in the biosynthesis of lipopeptides |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003025156A9 Methods and apparatuses for purification |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2003000204A8 Multivalent mycoplasma bacterin |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002046372A9 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 04/29/2004 | WO2002043649A8 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 04/29/2004 | WO2002033067A8 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082053 Thermostable glutaminase and thermostable glutaminase gene |
| 04/29/2004 | US20040082040 Amino acid-producing bacteria and a process for preparing L-amino acids |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082025 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081995 Dna polymerase; genetic engineering |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081965 Mutants; genetic engineering; amplification |
| 04/29/2004 | US20040081963 Joining polymerase to nucleic acids |
| 04/29/2004 | US20040081960 Novel process |
| 04/29/2004 | US20040081958 Identification and use of molecular markers indicating cellular reprogramming |
| 04/29/2004 | US20040081665 Chlorella preparations exhibiting immunomodulating properties |
| 04/29/2004 | US20040081663 Pharmaceutical composition for treatment and prevention of cancer and the preparation thereof |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | CA2502152A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 04/29/2004 | CA2498213A1 Induction of gene expression using a high concentration sugar mixture |
| 04/28/2004 | EP1413675A1 Method for reducing slime production and its composition |
| 04/28/2004 | EP1413585A2 Novel, recombinantly produced spider silk analogs |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412538A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412490A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 04/28/2004 | EP1412473A1 Bioreactor provided with equipment with flexible walls |
| 04/28/2004 | EP1412472A2 Bio-reactor |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |